i4KIDS and AstraZeneca: Finalists at the VIII SaluDigital Awards

The Pediatric Innovation Challenge, led by i4KIDS and AstraZeneca, was a finalist at the VIII SaluDigital Awards for its innovative approach to reducing the impact of paediatric influenza through advanced technology. This recognition highlights its contribution to the digital health sector.

The Pediatric Innovation Challenge, led by i4KIDS in collaboration with AstraZeneca, has been recognised as a finalist in the VIII edition of the SaluDigital Awards. This event, organised annually by Grupo Mediforum, highlights the most innovative initiatives in the field of digital health across both public and private sectors.

The proposal from i4KIDS and AstraZeneca competed in the “Best Private Initiative” category, standing out among more than 100 entries. The challenge, focused on reducing the impact of paediatric influenza and improving vaccination coverage, was praised for its collaborative and technological approach. The winning solution of the challenge, developed by Arkangel AI and unveiled during the #4YFN 2024 Congress, employs artificial intelligence to mitigate the effects of influenza in children.

Recognition in the Digital Health Sector

The SaluDigital Awards, sponsored by Quirónsalud, COFARES, Linde, and Telómera, aim to identify and reward initiatives that enhance quality of life and health through technological innovation. The awards ceremony was held in Madrid, where the value of projects transforming healthcare through innovative digital strategies was celebrated.

Although the i4KIDS and AstraZeneca project did not secure the top prize, its status as a finalist underscores the significance of their collaboration in advancing paediatric health. This recognition places the Pediatric Innovation Challenge as a standout model of how technological innovation can address critical challenges in healthcare.

For further details about the SaluDigital Awards, visit the official website here.

Related News

Featured

i4KIDS celebrates the presentation of the National Award for Knowledge Transfer Promotion 2024

The paediatric innovation hub i4KIDS has received the 2024 National Award for the Promotion of Knowledge Transfer. The award ceremony took place at the Teatre Nacional de Catalunya, presided over by the President of the Government of Catalonia, Salvador Illa, with Minister Núria Montserrat acting as host. The award recognises i4KIDS’ transformative impact in transferring knowledge to the market and highlights its role in mobilising investment and generating value in the healthcare sector. The award was accepted by Arnau Valls and Dr Joan Comella, accompanied by a large delegation from Sant Joan de Déu Hospital.

Featured

i4KIDS Acceleration Programme selects seven projects for its 2025 edition

The i4KIDS acceleration programme kicks off its 2025 edition with seven innovative projects in fetal, paediatric, and maternal health. Five of these come from i4KIDS member organisations, while two are from the ITEMAS network. Over six months, they will receive training and mentoring in clinical validation and market access. The programme will conclude at the Pediatric Innovation Day on 20 November in Barcelona.

Featured

i4KIDS joins CRAASH Barcelona Acceleration Programme to boost paediatric innovation

i4KIDS has joined the 8th edition of the CRAASH Barcelona programme, led by Biocat, as a new strategic partner. This collaboration reinforces the commitment to paediatric health innovation by ensuring the inclusion of at least one project in this field. The initiative complements i4KIDS’ recently launched acceleration programme, with both offering distinct yet complementary goals: while i4KIDS supports early-stage projects (TRL 2–4) through tailored valorisation, CRAASH Barcelona focuses on more advanced solutions (TRL 3–6) and their clinical and market validation.